Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P26
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -33.33% |
| Q2 2025 | 1761.54% |
| Q1 2025 | -36.84% |
| Q4 2024 | 83.48% |
| Q3 2024 | -4374.71% |
| Q2 2024 | 97.98% |
| Q1 2024 | 28.65% |
| Q4 2023 | -13383.58% |
| Q3 2023 | -45.75% |
| Q2 2023 | -5.00% |
| Q1 2023 | -13.33% |
| Q4 2022 | 69.49% |
| Q3 2022 | 580.77% |
| Q2 2022 | 117.45% |
| Q1 2022 | -2.05% |
| Q4 2021 | -7.35% |
| Q3 2021 | -17.24% |
| Q2 2021 | -96.61% |
| Q1 2021 | 50.42% |
| Q4 2020 | 0.00% |